Biotech Analyst Kamauskas holds a conference call with CEO Mehta and CMO Risinger on March 1 at 1 pm hosted by Truist. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BTAI:
- BioXcel Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
- BioXcel Therapeutics to hold Key Opinion Leader Day
- BioXcel Therapeutics price target raised to $79 from $73 at H.C. Wainwright
- BioXcel Therapeutics Announces Positive Full Data from Phase 2 Trial of BXCL701 in Rare, Aggressive Form of Prostate Cancer; to be Presented at 2023 ASCO Genitourinary Cancers Symposium
- BioXcel announces seven patients achieve composite response in BXCL701 trial